Safe Doses of Dextromethorphan
For adults, dextromethorphan is safely dosed at 10-30 mg three to four times daily, with a maximum daily dose of 120 mg; for children, dosing is age-based with 2.5-5 mL every 12 hours for ages 4-6 years, 5 mL every 12 hours for ages 6-12 years, and 10 mL every 12 hours for those 12 years and older, not exceeding 20 mL in 24 hours. 1
Adult Dosing
The FDA-approved dosing for adults and children ≥12 years is 10 mL every 12 hours, not exceeding 20 mL in 24 hours for extended-release formulations 1. For immediate-release formulations used as an antitussive, guidelines support 10-15 mg three to four times daily, with some publications citing 10-30 mg per dose and a maximum of 120 mg/day 2.
Important caveat: While standard over-the-counter dosing is typically subtherapeutic for cough suppression, maximum cough reflex suppression occurs at 60 mg single doses 3. However, care must be taken when recommending higher doses since many combination preparations contain additional ingredients like acetaminophen that could reach toxic levels 3.
Pediatric Dosing
Age-based dosing is critical for children:
- Ages 4 to <6 years: 2.5 mL every 12 hours (maximum 5 mL/24 hours)
- Ages 6 to <12 years: 5 mL every 12 hours (maximum 10 mL/24 hours)
- Ages ≥12 years: 10 mL every 12 hours (maximum 20 mL/24 hours)
- Children <4 years: Do not use 1
Research suggests that weight-based dosing may be more appropriate, with 0.5 mg/kg potentially offering better symptom control while balancing adverse events 4. However, this is not yet standard practice.
Toxicity Thresholds and Safety Considerations
Poison control guidelines provide clear toxicity thresholds:
- 5-7.5 mg/kg: Requires poison center follow-up every 2 hours for up to 4 hours; refer to emergency department if more than mild symptoms develop 5
- >7.5 mg/kg: Immediate referral to emergency department 5
- Suicidal intent or intentional abuse: Always refer to emergency department 5
Critical drug interactions: Patients taking monoamine oxidase inhibitors (MAOIs) or selective serotonin reuptake inhibitors (SSRIs) require poison center follow-up every 2 hours for 8 hours due to serotonin syndrome risk 5. The FDA has restricted prescription opioid-containing cough medications to adults ≥18 years as of 2018 6.
Clinical Context and Efficacy
The evidence for dextromethorphan's efficacy is mixed. While it has been shown to suppress acute cough in meta-analyses 3, multiple studies show no significant difference in cough frequency or severity compared to placebo, particularly in children 7. The 2006 ACCP guidelines rate antitussive agents for acute bronchitis as having "fair quality of evidence, small/weak benefit, Grade C recommendation" 8.
For children specifically, over-the-counter cough medications containing dextromethorphan are associated with adverse events and should not be prescribed until proven to make cough less severe or resolve sooner 6. Codeine-containing medications should be avoided in children due to potential for serious side effects including respiratory distress 6.
Adverse Effects
Common adverse effects include nausea, vomiting, motor impairment, and cognitive slowing, which become more prominent above 200 mg 9. At supratherapeutic doses, dextromethorphan causes CNS effects including hyperexcitability, increased muscle tone, ataxia, and psychoactive effects 10, 11. Deaths have been reported with intentional overdose 10.
In case of overdose: Contact Poison Control immediately (1-800-222-1222) 1. Naloxone can be considered for sedated or comatose patients with respiratory depression 5. Do not induce emesis or delay transportation to administer activated charcoal 5.